Biotricity Inc. (BTCY) stock
BTCYOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
$0.05+0.00 (+8.70%)
Close on Oct 19, 2026Market cap $1.15MP/E –Yield –
Biotricity operating margin
Operating margin is operating income as a percentage of revenue.
Biotricity's operating margin for the twelve months ending Jun 30, 2026 was 9.6%. For fiscal 2026 it was 10.6%, against -17.8% the year before. The highest annual figure on record is 10.6% in fiscal 2026.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | 10.6% | +28.3 |
| FY2025 | Mar 31, 2025 | -17.8% | +55.4 |
| FY2024 | Mar 31, 2024 | -73.2% | +86.7 |
| FY2023 | Mar 31, 2023 | -159.9% | +58.9 |
| FY2022 | Mar 31, 2022 | -218.8% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | 3.7% | −3.6 |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | 16.3% | +39.4 |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | 11.1% | +15.7 |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | 7.0% | +16.5 |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | 7.3% | +42.2 |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | -23.1% | +72.7 |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | -4.7% | +38.4 |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | -9.4% | +66.2 |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | -34.9% | +41.8 |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | -95.8% | +30.1 |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | -43.1% | +113.0 |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | -75.6% | +102.7 |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -76.7% | +168.7 |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -125.9% | – |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | -156.1% | – |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | -178.3% | – |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | -245.3% | – |
See a number that looks wrong?